Detection of 3-iodothyronamine in human patients: A preliminary study

Elena Galli, Maja Marchini, Alessandro Saba, Sergio Berti, Massimo Tonacchera, Paolo Vitti, Thomas (Tom) Scanlan, Giorgio Iervasi, Riccardo Zucchi

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Context and Objective: The primary purpose of this study was to detect and quantify 3-iodothyronamine (T 1AM), an endogenous biogenic amine related to thyroid hormone, in human blood. Design: T 1AM, total T 3, and total T 4 were assayed in serum by a novel HPLC tandem mass spectrometry assay, which has already been validated in animal investigations, and the results were related to standard clinical and laboratory variables. Setting and Patients: The series included one healthy volunteer, 24 patients admitted to a cardiological ward, and 17 ambulatory patients suspected of thyroid disease, who underwent blood sampling at admission for routine diagnostic purposes. Seven patients were affected by type 2 diabetes, and six patients showed echocardiographic evidence of impaired left ventricular function. Interventions: No intervention or any patient selection was performed. Main Outcome Measures: serum T 1AM, total and free T 3 and T 4, routine chemistry, routine hematology, and echocardiographic parameters were measured. Results: T 1AM was detected in all samples, and its concentration averaged 0.219 ± 0.012 pmol/ml. The T 1AM concentration was significantly correlated to total T 4 (r = 0.654, P <0.001), total T 3 (r = 0.705, P <0.001), glycated hemoglobin (r = 0.508, P = 0.013), brain natriuretic peptide (r = 0.543, P = 0.016), and γ-glutamyl transpeptidase (r = 0.675, P <0.001). In diabetic vs. nondiabetic patients T 1AM concentration was significantly increased (0.232 ± 0.014 vs. 0.203 ± 0.006 pmol/ml, P = 0.044), whereas no significant difference was observed in patients with cardiac dysfunction. Conclusions: T 1AM is an endogenous messenger that can be assayed in human blood. Our results are consistent with the hypothesis that circulating T 1AM is produced from thyroid hormones and encourage further investigations on the potential role of T 1AM in insulin resistance and heart failure.

Original languageEnglish (US)
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Blood
Thyroid Hormones
Biogenic Amines
gamma-Glutamyltransferase
Brain Natriuretic Peptide
Glycosylated Hemoglobin A
Medical problems
Mass spectrometry
Assays
Animals
Insulin
Sampling
Thyroid Diseases
Hematology
Tandem Mass Spectrometry
3-iodothyronamine
Serum
Left Ventricular Function
Type 2 Diabetes Mellitus
Patient Selection

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Galli, E., Marchini, M., Saba, A., Berti, S., Tonacchera, M., Vitti, P., ... Zucchi, R. (2012). Detection of 3-iodothyronamine in human patients: A preliminary study. Journal of Clinical Endocrinology and Metabolism, 97(1). https://doi.org/10.1210/jc.2011-1115

Detection of 3-iodothyronamine in human patients : A preliminary study. / Galli, Elena; Marchini, Maja; Saba, Alessandro; Berti, Sergio; Tonacchera, Massimo; Vitti, Paolo; Scanlan, Thomas (Tom); Iervasi, Giorgio; Zucchi, Riccardo.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 1, 01.2012.

Research output: Contribution to journalArticle

Galli, E, Marchini, M, Saba, A, Berti, S, Tonacchera, M, Vitti, P, Scanlan, TT, Iervasi, G & Zucchi, R 2012, 'Detection of 3-iodothyronamine in human patients: A preliminary study', Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 1. https://doi.org/10.1210/jc.2011-1115
Galli, Elena ; Marchini, Maja ; Saba, Alessandro ; Berti, Sergio ; Tonacchera, Massimo ; Vitti, Paolo ; Scanlan, Thomas (Tom) ; Iervasi, Giorgio ; Zucchi, Riccardo. / Detection of 3-iodothyronamine in human patients : A preliminary study. In: Journal of Clinical Endocrinology and Metabolism. 2012 ; Vol. 97, No. 1.
@article{6aaefc3b05ff41789f6f52c47bd400ba,
title = "Detection of 3-iodothyronamine in human patients: A preliminary study",
abstract = "Context and Objective: The primary purpose of this study was to detect and quantify 3-iodothyronamine (T 1AM), an endogenous biogenic amine related to thyroid hormone, in human blood. Design: T 1AM, total T 3, and total T 4 were assayed in serum by a novel HPLC tandem mass spectrometry assay, which has already been validated in animal investigations, and the results were related to standard clinical and laboratory variables. Setting and Patients: The series included one healthy volunteer, 24 patients admitted to a cardiological ward, and 17 ambulatory patients suspected of thyroid disease, who underwent blood sampling at admission for routine diagnostic purposes. Seven patients were affected by type 2 diabetes, and six patients showed echocardiographic evidence of impaired left ventricular function. Interventions: No intervention or any patient selection was performed. Main Outcome Measures: serum T 1AM, total and free T 3 and T 4, routine chemistry, routine hematology, and echocardiographic parameters were measured. Results: T 1AM was detected in all samples, and its concentration averaged 0.219 ± 0.012 pmol/ml. The T 1AM concentration was significantly correlated to total T 4 (r = 0.654, P <0.001), total T 3 (r = 0.705, P <0.001), glycated hemoglobin (r = 0.508, P = 0.013), brain natriuretic peptide (r = 0.543, P = 0.016), and γ-glutamyl transpeptidase (r = 0.675, P <0.001). In diabetic vs. nondiabetic patients T 1AM concentration was significantly increased (0.232 ± 0.014 vs. 0.203 ± 0.006 pmol/ml, P = 0.044), whereas no significant difference was observed in patients with cardiac dysfunction. Conclusions: T 1AM is an endogenous messenger that can be assayed in human blood. Our results are consistent with the hypothesis that circulating T 1AM is produced from thyroid hormones and encourage further investigations on the potential role of T 1AM in insulin resistance and heart failure.",
author = "Elena Galli and Maja Marchini and Alessandro Saba and Sergio Berti and Massimo Tonacchera and Paolo Vitti and Scanlan, {Thomas (Tom)} and Giorgio Iervasi and Riccardo Zucchi",
year = "2012",
month = "1",
doi = "10.1210/jc.2011-1115",
language = "English (US)",
volume = "97",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Detection of 3-iodothyronamine in human patients

T2 - A preliminary study

AU - Galli, Elena

AU - Marchini, Maja

AU - Saba, Alessandro

AU - Berti, Sergio

AU - Tonacchera, Massimo

AU - Vitti, Paolo

AU - Scanlan, Thomas (Tom)

AU - Iervasi, Giorgio

AU - Zucchi, Riccardo

PY - 2012/1

Y1 - 2012/1

N2 - Context and Objective: The primary purpose of this study was to detect and quantify 3-iodothyronamine (T 1AM), an endogenous biogenic amine related to thyroid hormone, in human blood. Design: T 1AM, total T 3, and total T 4 were assayed in serum by a novel HPLC tandem mass spectrometry assay, which has already been validated in animal investigations, and the results were related to standard clinical and laboratory variables. Setting and Patients: The series included one healthy volunteer, 24 patients admitted to a cardiological ward, and 17 ambulatory patients suspected of thyroid disease, who underwent blood sampling at admission for routine diagnostic purposes. Seven patients were affected by type 2 diabetes, and six patients showed echocardiographic evidence of impaired left ventricular function. Interventions: No intervention or any patient selection was performed. Main Outcome Measures: serum T 1AM, total and free T 3 and T 4, routine chemistry, routine hematology, and echocardiographic parameters were measured. Results: T 1AM was detected in all samples, and its concentration averaged 0.219 ± 0.012 pmol/ml. The T 1AM concentration was significantly correlated to total T 4 (r = 0.654, P <0.001), total T 3 (r = 0.705, P <0.001), glycated hemoglobin (r = 0.508, P = 0.013), brain natriuretic peptide (r = 0.543, P = 0.016), and γ-glutamyl transpeptidase (r = 0.675, P <0.001). In diabetic vs. nondiabetic patients T 1AM concentration was significantly increased (0.232 ± 0.014 vs. 0.203 ± 0.006 pmol/ml, P = 0.044), whereas no significant difference was observed in patients with cardiac dysfunction. Conclusions: T 1AM is an endogenous messenger that can be assayed in human blood. Our results are consistent with the hypothesis that circulating T 1AM is produced from thyroid hormones and encourage further investigations on the potential role of T 1AM in insulin resistance and heart failure.

AB - Context and Objective: The primary purpose of this study was to detect and quantify 3-iodothyronamine (T 1AM), an endogenous biogenic amine related to thyroid hormone, in human blood. Design: T 1AM, total T 3, and total T 4 were assayed in serum by a novel HPLC tandem mass spectrometry assay, which has already been validated in animal investigations, and the results were related to standard clinical and laboratory variables. Setting and Patients: The series included one healthy volunteer, 24 patients admitted to a cardiological ward, and 17 ambulatory patients suspected of thyroid disease, who underwent blood sampling at admission for routine diagnostic purposes. Seven patients were affected by type 2 diabetes, and six patients showed echocardiographic evidence of impaired left ventricular function. Interventions: No intervention or any patient selection was performed. Main Outcome Measures: serum T 1AM, total and free T 3 and T 4, routine chemistry, routine hematology, and echocardiographic parameters were measured. Results: T 1AM was detected in all samples, and its concentration averaged 0.219 ± 0.012 pmol/ml. The T 1AM concentration was significantly correlated to total T 4 (r = 0.654, P <0.001), total T 3 (r = 0.705, P <0.001), glycated hemoglobin (r = 0.508, P = 0.013), brain natriuretic peptide (r = 0.543, P = 0.016), and γ-glutamyl transpeptidase (r = 0.675, P <0.001). In diabetic vs. nondiabetic patients T 1AM concentration was significantly increased (0.232 ± 0.014 vs. 0.203 ± 0.006 pmol/ml, P = 0.044), whereas no significant difference was observed in patients with cardiac dysfunction. Conclusions: T 1AM is an endogenous messenger that can be assayed in human blood. Our results are consistent with the hypothesis that circulating T 1AM is produced from thyroid hormones and encourage further investigations on the potential role of T 1AM in insulin resistance and heart failure.

UR - http://www.scopus.com/inward/record.url?scp=84855514921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855514921&partnerID=8YFLogxK

U2 - 10.1210/jc.2011-1115

DO - 10.1210/jc.2011-1115

M3 - Article

C2 - 22031514

AN - SCOPUS:84855514921

VL - 97

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -